[
    [
        {
            "time": "",
            "original_text": "大参林公开发行可转债申请获核准批复",
            "features": {
                "keywords": [
                    "大参林",
                    "公开发行",
                    "可转债",
                    "核准",
                    "批复"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "大参林公开发行可转债申请获核准批复",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "大参林(603233.SH)公开发行可转债申请获中国证监会核准",
            "features": {
                "keywords": [
                    "大参林",
                    "603233.SH",
                    "公开发行",
                    "可转债",
                    "中国证监会",
                    "核准"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "大参林(603233.SH)公开发行可转债申请获中国证监会核准",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "大参林(603233)2020年中报点评：收入增长管理效益提升 公司业绩逆势上扬",
            "features": {
                "keywords": [
                    "大参林",
                    "603233",
                    "2020年中报",
                    "收入增长",
                    "管理效益",
                    "提升",
                    "业绩",
                    "逆势上扬"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大参林(603233)2020年中报点评：收入增长管理效益提升 公司业绩逆势上扬",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]